Boston Sci Wins Latest TAVR Patent Dispute Against Edwards
Executive Summary
The European Patent Office sided with Boston Scientific on April 16 in agreeing to revoke an Edwards Lifesciences patent on a technology used in transcatheter aortic valve replacement (TAVR) devices.